0001387131-23-011359.txt : 20230919 0001387131-23-011359.hdr.sgml : 20230919 20230919171724 ACCESSION NUMBER: 0001387131-23-011359 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230915 FILED AS OF DATE: 20230919 DATE AS OF CHANGE: 20230919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versi Ebrahim CENTRAL INDEX KEY: 0001978256 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36242 FILM NUMBER: 231264669 MAIL ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: STE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DMK PHARMACEUTICALS Corp CENTRAL INDEX KEY: 0000887247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820429727 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 997-2400 MAIL ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Adamis Pharmaceuticals Corp DATE OF NAME CHANGE: 20090406 FORMER COMPANY: FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950615 4 1 versi-form4_091223.xml FORM 4 - VERSI X0508 4 2023-09-15 0 0000887247 DMK PHARMACEUTICALS Corp DMK 0001978256 Versi Ebrahim C/O DMK PHARMACEUTICALS CORPORATION 11682 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 1 1 0 0 CEO 0 Common Stock 2023-09-15 4 C 0 729200 0 A 906394 I By Versi Group LLC Common Stock 8745 D Series E Convertible Preferred Stock 2023-09-15 4 C 0 729.2 0 D 2023-05-25 Common Stock 729200 1212 I By Versi Group LLC On September 15, 2023, Versi Group, LLC converted 729.2 shares of Series E Convertible Preferred Stock ("Series E Preferred") into 729,200 shares of Common Stock, pursuant to the terms of the Series E Preferred. Each share of Series E Preferred is convertible into 1,000 shares of Common Stock at the election of the reporting person, subject to certain beneficial ownership limitations. The Series E Preferred has no expiration date. The reported shares are owned directly by Versi Group, LLC, of which the reporting person is the manager and a member. The reporting person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interests therein. /s/ David J. Marguglio, as Attorney-in-Fact for Ebrahim Versi 2023-09-19